In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

DexCom Inc.'s Series C brings in $30mm

08 Jan 2007

Executive Summary

DexCom Inc. (developing an implantable glucose monitor for diabetics) raised $30mm in its third financing round, which was led by RWI Group.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Implantable Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By